San Francisco Biotech Networks

San Francisco Biotech Professionals: Make meaningful connections Dec. 2nd at Biotech Networks Speed Networking. https://sfbn.org/bndec24 We take the work ?? out of networking! We'll be back at Harmonic Brewing in Mission Bay, where these photos were taken. We've got a full buyout so regardless of the weather, we'll have a cozy indoor spot with the option of great views of the bay. The location has good parking ?? and is transit-friendly. Harmonic has GREAT catering and we will NOT be serving Turkey ?? so we've got that going for us.... JOIN US! https://sfbn.org/bndec24 #networking #sanfrancisco #bayarea #lifescience #biotech #drugdevelopment #drugdiscovery

SFBN Feed: Cataloging the Microbiome of U.S. Rivers https://lnkd.in/gYsszATQ The post Cataloging the Microbiome of U.S. Rivers appeared first on Berkeley Lab News Center. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Redefining the Standard of Care: Introducing the Aulisa? Monitor Camera for Advanced Patient Monitoring https://lnkd.in/gr-mVvjt PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ — Aulisa? Medical USA, Inc., a leader in FDA-cleared, wearable, wireless continuous vital sign monitoring technology, proudly announces the launch of the Aulisa? Monitor Camera, an innovative solution [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: The Children's Inn at NIH Announces $1 Million Grant From Gilead Sciences, Inc. https://lnkd.in/gvBT27Bq BETHESDA, Md.–(BUSINESS WIRE)–The Children’s Inn at the National Institutes of Health (NIH) today announced that Gilead Sciences Inc. has awarded The Inn a $1 million grant to support its renovation and expansion. The grant will [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Cyclum Announces New Executives to Lead Next Generation Travel Centre Growth https://lnkd.in/g_DpxNfH CORNELIUS, N.C.–(BUSINESS WIRE)–Cyclum, an innovator in zero carbon fuels and next generation travel centers, is proud to announce a new executive team to lead its next phase of growth. Cyclum plans to build 400 state-of-the-art [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Development poised to add 800 health care jobs https://lnkd.in/g3_5y3ig A health care giant is working on a 650,000-square-foot hospital, expected to open in 2029. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset https://lnkd.in/gupVfWDX SAN JOSE, Calif., Nov. 22, 2024 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Board of Directors [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Scilex Holding Company Announces Receipt of Notice from Nasdaq https://lnkd.in/gwKPJE6P PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Ariz Precision Medicine pitch earns $110,000 investment at AngelCon https://lnkd.in/gJYt4zJe A group of 13 newly minted angel investors put $110,000 into Davis-based Ariz Precision Medicine, a medical research startup developing nanotechnology cancer therapy drugs. Click here to view original post Click Here to Publish/Feature Your [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a Groundbreaking Gene Therapy for Wet AMD Including PCV https://lnkd.in/g9FXSRXJ HAYWARD, Calif., Nov. 21, 2024 /PRNewswire/ — Avirmax Biopharma, Inc., a leader in the development of innovative gene therapies, today announced that the first patient has been successfully dosed in the Phase I/IIa clinical trial [...] #BayArea #SanFrancisco #Biotech #Lifescience #News